FNUSA ICRC
FNUSA ICRC is a non-profit clinical research center jointly operated by St. Anne's University Hospital Brno and Masaryk University's Faculty of Medicine, conducting translational research in neuroscience, oncology, cardiovascular medicine, and protein engineering, funded through European and Czech national grants and serving academic, clinical, and student stakeholders.
- Company typePrivate
- Founded2012
- HeadquartersBrno, Czechia
- Headcount1,001–5,000
- GTM typeB2B
- OfferingServices
What FNUSA ICRC does
FNUSA ICRC (International Clinical Research Center / Mezinárodní centrum klinického výzkumu FNUSA a LF MU) is a non-profit clinical research institution jointly operated by St. Anne's University Hospital Brno (FNUSA) and the Faculty of Medicine at Masaryk University, founded in 2012 and headquartered in Brno, Czech Republic. The center conducts translational and preclinical research across neuroscience, oncology, cardiovascular medicine, molecular biology, and protein engineering, with dedicated research teams in Neuromodulation Technologies, Mechanobiology of Disease, Cell and Tissue Regeneration, and Molecular Control of Immune Response. Its technical platform combines advanced capabilities including HDX-MS protein structure analysis (via Masaryk Memorial Cancer Institute), Temporal Interference non-invasive brain stimulation paired with fMRI, nanoparticle-based drug delivery systems, patient-derived organoid/3D tumor models, and FAIR-compliant data publishing through repositories such as EBRAINS and FigShare.
The center has no commercial pricing model; revenue is generated entirely through research grants and institutional funding from the European Commission (HORIZON 2020, HRS4R, European Regional Development Fund), Czech national agencies (TAČR, GAČR, AZV ČR), operational support from FNUSA and Masaryk University, and international consortium funding such as the CLARA excellence center. Its go-to-market approach is event- and partnership-driven, operating through the annual ICRC DAYS conference, public science events like Brain Week (Týden mozku), the ICRC Academy internship/seminar program, and bilateral research partnerships with institutions including Yale University, University of Melbourne, Gyeongsang National University, CIIRC, and CEITEC. Customer segments are academic researchers, graduate and postgraduate students, clinical collaborators at FNUSA, and international consortium partners, with patient access provided through co-location at the university hospital for clinical trial recruitment.
FNUSA ICRC firmographics
Firmographics- Name
- FNUSA ICRC
- Legal name
- Mezinárodní centrum klinického výzkumu FNUSA a LF MU (ICRC)
- Website
- https://fnusa-icrc.org
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- FNUSA ICRC is a non-profit clinical research center jointly operated by St. Anne's University Hospital Brno and Masaryk University's Faculty of Medicine, conducting translational research in neuroscience, oncology, cardiovascular medicine, and protein engineering, funded through European and Czech national grants and serving academic, clinical, and student stakeholders.
- Ownership category
- akta.pro rank
FNUSA ICRC industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industry
- Medical Writing & Clinical Documentation FSP (HLAGAOAC)
Keywords
Where FNUSA ICRC is headquartered
LocationHeadquarters
- HQ city
- Brno
- HQ country
- Czechia
- HQ region
- Europe
Offices1 record
Markets served
FNUSA ICRC business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Research Grants and Funding: Funding from European Commission programs (HORIZON 2020, HRS4R), Czech national programs (TAČR, GAČR, AZV ČR), and operational support from parent institutions (FNUSA and Masaryk University). The Brno Ph.D. Talent program provides 360,000 CZK per student over 3 years.
- HR Award Implementation Project: Project 'Implementation of HR AWARD Standard in FNUSA-ICRC' supported by European Regional Development Fund (reg. č. CZ.02.2.69/0.0/0.0/18_054/0014678) through the Education for Competitiveness Operational Programme.
- CLARA Consortium Funding: Interdisciplinary center of excellence funded through international partnerships to accelerate neurodegenerative disease research using AI, machine learning, and quantum computing technologies.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
FNUSA ICRC product offering
Product offeringCore offering
FNUSA ICRC (International Clinical Research Center) is a joint workplace of St. Anne's University Hospital Brno (FNUSA) and the Faculty of Medicine at Masaryk University that conducts clinical and preclinical research across neuroscience, oncology, cardiovascular medicine, and molecular biology. The center delivers translational research services including protein engineering for thrombolytic drug development, temporal interference neuromodulation for neurological disorders, and nanoparticle-based cancer therapies. It also provides training programs (ICRC Academy), fellowship opportunities (Brno Ph.D. Talent), and data management services following FAIR principles through repositories such as EBRAINS.
Product overview
FNUSA ICRC (International Clinical Research Center) is a joint research institution of St. Anne's University Hospital Brno and Masaryk University Faculty of Medicine. It operates as a comprehensive clinical research center offering multiple research programs including neuroscience, protein engineering, neuromodulation, cancer research, and mechanobiology. The institution provides education through the ICRC Academy, supports young researchers via the Brno Ph.D. Talent program, and participates in the CLARA consortium for AI-driven neurodegenerative disease research. Core offerings include clinical and preclinical research services, data management, and training programs rather than commercial products.
Differentiator
Problem solved
Functional benefit
Brands
- ICRC Academy: Educational program providing internships and weekend seminars for students interested in clinical research
- HR Award (HR Excellence in Research)
- CLARA Young Innovator Award
- ICRC DAYS
Products and services
- ICRC Academy
Quantifiable outcome
- 5 PhD students awarded in Brno Ph.D. Talent 2026 program out of 151 applicants
- +3 more outcomes
Companies that use FNUSA ICRC
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles4 records
FNUSA ICRC technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature6 records
FNUSA ICRC partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core, minor and major.
- Gyeongsang National University (South Korea)coreInternational research collaboration focused on understanding mechanisms of tumor fibrosis in pancreatic cancer and developing nanoparticle-based treatments. Combines biological research with nanomaterial technologies and provides mutual access to unique laboratory facilities.
- University of Ljubljana (Slovenia)minorHosting of delegation from Faculty of Medicine for laboratory tours and research exchange, representing oldest university in Slovenia.
- Alliance4Life ConsortiumcoreStrategic project of 10 leading life science institutions from 9 Central and Eastern European countries aimed at addressing research excellence gaps. Includes HR reform initiatives and research culture assessments.
- Yale University (USA)coreInternational cooperation in neurological research established through a postgraduate education programme for clinical research collaboration.
- Masaryk Memorial Cancer InstitutecoreProvides HDX-MS facility access for protein structure analysis, enabling ICRC researchers to study protein dynamics and support drug development projects including staphylokinase engineering.
- Loschmidt Laboratories (FNUSA-ICRC and Masaryk University)corePerforms rational protein design for staphylokinase variants, reducing immunogenic hotspots and enhancing thrombolytic activity for stroke treatment.
- CIIRC (Czech Technical University in Prague)coreCollaborates on AI-driven protein design and computational modeling for engineering therapeutic protein variants.
- Institute of Biophysics, Academy of Sciences of the Czech RepublicmajorPerforms immunogenicity screening and functional assays for engineered protein variants.
- Palacký University OlomoucmajorCollaborates on plasma-based experiments and immunogenicity screening for thrombolytic protein research.
- CLARA Consortium PartnerscoreCLARA is an interdisciplinary center of excellence focusing on AI, machine learning, and quantum computing for neurodegenerative disease research. Partners include INDRC, ICRC, CIIRC, VSB-TUO IT4Innovations, Paris Brain Institute, and Leibniz Supercomputing Centre.
- University of Melbourne (Australia)coreMSCA Fellowships Mobility Support enables researcher exchanges for advanced nanoparticle research combining expertise from Brno and Melbourne teams.
- CEITEC (Central European Institute of Technology)coreProvides access to advanced imaging techniques including magnetic resonance imaging (MRI) for neuroscience research conducted by ICRC Academy interns.
Scale indicators8 records
Recent moves7 records
Expansion highlights6 records
FNUSA ICRC competitors and assessment
Company assessmentMarket position
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
FNUSA ICRC social profiles
Digital presenceFNUSA ICRC compliance and trust
Trust signalCompliance3 records
FNUSA ICRC financial estimates
Financial estimateRevenue estimate
Valuation estimate
FNUSA ICRC leadership team
Management profileNumber of profiles
Profiles8 records
FNUSA ICRC funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
FNUSA ICRC M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about FNUSA ICRC
What does FNUSA ICRC do?
FNUSA ICRC (International Clinical Research Center) is a joint workplace of St. Anne's University Hospital Brno (FNUSA) and the Faculty of Medicine at Masaryk University that conducts clinical and preclinical research across neuroscience, oncology, cardiovascular medicine, and molecular biology. The center delivers translational research services including protein engineering for thrombolytic drug development, temporal interference neuromodulation for neurological disorders, and nanoparticle-based cancer therapies. It also provides training programs (ICRC Academy), fellowship opportunities (Brno Ph.D. Talent), and data management services following FAIR principles through repositories such as EBRAINS.
Is FNUSA ICRC a public or private company?
FNUSA ICRC is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was FNUSA ICRC founded?
FNUSA ICRC was founded in 2012. It employs 1,001 to 5,000 people.
Where is FNUSA ICRC based?
FNUSA ICRC is headquartered in Brno, Czechia, in the Europe region.
How does FNUSA ICRC make money?
Three revenue lines are on record. Research Grants and Funding is the primary driver. The others are HR Award Implementation Project and CLARA Consortium Funding.
Does FNUSA ICRC have an API?
No public API is recorded for FNUSA ICRC.
What industry is FNUSA ICRC in?
FNUSA ICRC's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLAGAOAC, Medical Writing & Clinical Documentation FSP. Its NAICS code is 54171 and its SIC code is 8731.